Regulatory and clinical roadblocks have set back its oral BTK inhibitor tolebrutinib, but the drug class still has many ...

Scientists have discovered that blocking a key cellular enzyme thought to protect against fatty liver disease may instead ...

A new and important discovery comes from the field of oncological research thanks to the joint work of researchers from the ...

Scientists have discovered that blocking a key cellular enzyme thought to protect against fatty liver disease may instead increase the risk of chronic liver damage and cancer as we age.

The research has generated significant interest from firms in food & supplements as consumers seek natural alternatives to ...

Adenosine deaminase acting on RNA (ADAR) is the enzyme responsible for adenosine-to-inosine (A-to-I) RNA editing, a process ...

Researchers have discovered that mimicking cold exposure or fasting can trigger an immune response in the body that slows ...

Published in Science Advances, the study found that loss of the enzyme Caspase-2 drives abnormal growth in liver cells, triggering inflammation, fibrosis, and a significantly higher risk of liver ...